2024-07-26 07:16:19 ET
More on Bristol-Myers Squibb Company
- Bristol-Myers Squibb - Investors Are Too Long-Term Focused
- Bristol-Myers Squibb Is A Bargain Now
- Is Bristol-Myers Squibb's Rich Dividend Yield Worth The Patent Cliff Correction Risk?
- Bristol-Myers Squibb Company Non-GAAP EPS of $2.07 beats by $0.44, revenue of $12.2B beats by $680M
- Bristol-Myers Squibb Q2 Earnings Preview: Strong results on the back of legacy portfolio
Read the full article on Seeking Alpha
For further details see:
Earnings summary: Bristol-Myers Squibb Q2 results top estimates, raises adj. EPS outlook